Antonio Rullan

1.5k total citations
31 papers, 987 citations indexed

About

Antonio Rullan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Antonio Rullan has authored 31 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Antonio Rullan's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers) and CAR-T cell therapy research (4 papers). Antonio Rullan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers) and CAR-T cell therapy research (4 papers). Antonio Rullan collaborates with scholars based in United Kingdom, Spain and Palestinian Territory. Antonio Rullan's co-authors include Erik Sahai, Danielle Park, Josep M. Piulats, Ignacio Melero, María E. Rodríguez-Ruiz, Alfonso R. Sánchez-Paulete, Nicola Tinari, Marc Oliva, Kevin J. Harrington and Alan Melcher and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Blood.

In The Last Decade

Antonio Rullan

28 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Rullan United Kingdom 13 426 382 343 171 118 31 987
Mizue Terai United States 19 453 1.1× 476 1.2× 424 1.2× 480 2.8× 95 0.8× 41 1.3k
Frank M. Speetjens Netherlands 20 617 1.4× 613 1.6× 326 1.0× 176 1.0× 137 1.2× 50 1.1k
Marlana Orloff United States 17 561 1.3× 393 1.0× 358 1.0× 604 3.5× 93 0.8× 80 1.1k
Marina Marinkovic Netherlands 23 466 1.1× 261 0.7× 355 1.0× 846 4.9× 127 1.1× 67 1.3k
Smita S. Chandran United States 13 670 1.6× 682 1.8× 261 0.8× 149 0.9× 51 0.4× 19 1.0k
Kalijn F. Bol Netherlands 21 1.1k 2.5× 1.3k 3.4× 523 1.5× 99 0.6× 114 1.0× 42 1.7k
Richard G. Everson United States 20 580 1.4× 568 1.5× 310 0.9× 22 0.1× 159 1.3× 84 1.5k
Sumaira Z. Aasi United States 24 411 1.0× 112 0.3× 563 1.6× 32 0.2× 113 1.0× 65 1.4k
Daniel A. Rodriguez United States 9 160 0.4× 188 0.5× 260 0.8× 205 1.2× 36 0.3× 25 570
Marie‐Paule Algros France 12 222 0.5× 125 0.3× 359 1.0× 29 0.2× 85 0.7× 30 743

Countries citing papers authored by Antonio Rullan

Since Specialization
Citations

This map shows the geographic impact of Antonio Rullan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Rullan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Rullan more than expected).

Fields of papers citing papers by Antonio Rullan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Rullan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Rullan. The network helps show where Antonio Rullan may publish in the future.

Co-authorship network of co-authors of Antonio Rullan

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Rullan. A scholar is included among the top collaborators of Antonio Rullan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Rullan. Antonio Rullan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hak, Charleen Chan Wah, Emmanuel C. Patin, Annalisa Nicastri, et al.. (2025). Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer. Cancer Research Communications. 5(11). 2079–2091.
2.
Hayes, Andrew, Emma Jane Davies, Michelle Wilkinson, et al.. (2025). Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunity. Journal for ImmunoTherapy of Cancer. 13(9). e012446–e012446. 1 indexed citations
3.
Fayette, Jérôme, Gerald A. Thomas, Amaury Daste, et al.. (2024). 853MO Setanaxib plus pembrolizumab for the treatment of recurrent or metastatic squamous cell carcinoma of the head & neck: Results of a randomized, double-blind phase II trial. Annals of Oncology. 35. S615–S616. 4 indexed citations
5.
Aymerich, Clàudia, Antonio Rullan, Irene Braña, et al.. (2024). Mapping the mental health correlates of head and neck cancer: A systemic review and meta-analysis.. Journal of Clinical Oncology. 42(16_suppl). 6077–6077.
6.
Rullan, Antonio, Víctor Moreno, Bernard Doger, et al.. (2024). Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives. Cancer Treatment Reviews. 127. 102746–102746. 6 indexed citations
7.
Aymerich, Clàudia, Irene Braña, Antonio Rullan, et al.. (2024). A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis. JNCI Cancer Spectrum. 8(3). 12 indexed citations
8.
Aymerich, Clàudia, Antonio Rullan, Jon Cacicedo, et al.. (2024). Prevalence of depressive and anxiety symptoms in patients with head and neck cancer undergoing radiotherapy: A systematic review and meta-analysis of longitudinal studies. Radiotherapy and Oncology. 202. 110649–110649. 1 indexed citations
9.
Nenclares, Pablo, Adrian Lärkeryd, Susan Lalondrelle, et al.. (2024). T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies. Frontiers in Oncology. 13. 1296948–1296948. 2 indexed citations
10.
Rullan, Antonio, Yutaka Naito, Dhruva Biswas, et al.. (2024). Cancer cell – Fibroblast crosstalk via HB-EGF, EGFR, and MAPK signaling promotes the expression of macrophage chemo-attractants in squamous cell carcinoma. iScience. 27(9). 110635–110635. 4 indexed citations
11.
Kato, Takuya, Robert P. Jenkins, Stefanie Derzsi, et al.. (2023). Interplay of adherens junctions and matrix proteolysis determines the invasive pattern and growth of squamous cell carcinoma. eLife. 12. 6 indexed citations
12.
Rullan, Antonio, et al.. (2022). Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy. Frontiers in Oncology. 12. 971959–971959. 23 indexed citations
13.
Rullan, Antonio, et al.. (2022). A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer. Frontiers in Oncology. 12. 1000888–1000888. 10 indexed citations
14.
Nenclares, Pablo, et al.. (2022). Introducing Checkpoint Inhibitors Into the Curative Setting of Head and Neck Cancers: Lessons Learned, Future Considerations. American Society of Clinical Oncology Educational Book. 42(42). 511–526. 21 indexed citations
15.
Park, Danielle, David J. Barry, Robert P. Jenkins, et al.. (2021). A FIJI macro for quantifying pattern in extracellular matrix. Life Science Alliance. 4(3). e202000880–e202000880. 86 indexed citations
16.
Park, Danielle, Erik Sahai, & Antonio Rullan. (2020). SnapShot: Cancer-Associated Fibroblasts. Cell. 181(2). 486–486.e1. 119 indexed citations
17.
Arwert, Esther N., Antonio Rullan, Stefanie Derzsi, et al.. (2020). STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy. Nature Cell Biology. 22(7). 758–766. 72 indexed citations
18.
Failmezger, Henrik, Sathya Muralidhar, Antonio Rullan, et al.. (2019). Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology. Cancer Research. 80(5). 1199–1209. 54 indexed citations
19.
Rullan, Antonio, Maria Saigí, Inmaculada Peiró, et al.. (2019). Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy. BMC Cancer. 19(1). 165–165. 26 indexed citations
20.
Taberna, Miren, Antonio Rullan, Cinta Hierro, et al.. (2015). Late toxicity after radical treatment for locally advanced head and neck cancer. Oral Oncology. 51(8). 795–799. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026